Eurofins Scientific SE
ERF: XPAR (FRA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€76.00 | Pxnkwb | Xdnndkkt |
Eurofins' Margin Under Pressure, Though COVID-19 and Pricing Power Supporting Top Line; Maintain FVE
Eurofins reported a mixed second quarter with surprisingly steady revenue growth and upbeat guidance, though this was offset by a decline in margin from a mix shift away from COVID-19 products and the effect of higher operating costs. We are maintaining our EUR 80 fair value estimate and narrow moat rating, and shares remain fairly valued even after a moderate share price decline following earnings.